» Articles » PMID: 20129061

TMEPAI, a Transmembrane TGF-beta-inducible Protein, Sequesters Smad Proteins from Active Participation in TGF-beta Signaling

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2010 Feb 5
PMID 20129061
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine of key importance for controlling embryogenesis and tissue homeostasis. How TGF-beta signals are attenuated and terminated is not well understood. Here, we show that TMEPAI, a direct target gene of TGF-beta signaling, antagonizes TGF-beta signaling by interfering with TGF-beta type I receptor (TbetaRI)-induced R-Smad phosphorylation. TMEPAI can directly interact with R-Smads via a Smad interaction motif. TMEPAI competes with Smad anchor for receptor activation for R-Smad binding, thereby sequestering R-Smads from TbetaRI kinase activation. In mammalian cells, ectopic expression of TMEPAI inhibited TGF-beta-dependent regulation of plasminogen activator inhibitor-1, JunB, cyclin-dependent kinase inhibitors, and c-myc expression, whereas specific knockdown of TMEPAI expression prolonged duration of TGF-beta-induced Smad2 and Smad3 phosphorylation and concomitantly potentiated cellular responsiveness to TGF-beta. Consistently, TMEPAI inhibits activin-mediated mesoderm formation in Xenopus embryos. Therefore, TMEPAI participates in a negative feedback loop to control the duration and intensity of TGF-beta/Smad signaling.

Citing Articles

Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy.

Yen Y, Zhang Z, Chen A, Qiu Y, Liu Q, Wang Q J Nanobiotechnology. 2025; 23(1):124.

PMID: 39972327 PMC: 11841268. DOI: 10.1186/s12951-025-03129-z.


Transmembrane Prostate Androgen-Induced Protein 1 Molecular Modeling and Refinement Using Coarse-Grained Molecular Dynamics.

Wicaksono I, Destiarani W, Romadhon S, Nugraha B, Yusuf M, Milanda T ACS Omega. 2025; 10(3):2712-2724.

PMID: 39895701 PMC: 11780462. DOI: 10.1021/acsomega.4c08451.


Cullin 4B-RING E3 ligase negatively regulates the immunosuppressive capacity of mesenchymal stem cells by suppressing iNOS.

Yu R, Han H, Chu S, Qin L, Du M, Ma Y Cell Death Differ. 2024; 32(1):149-161.

PMID: 39138375 PMC: 11748679. DOI: 10.1038/s41418-024-01359-6.


Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer.

Gottumukkala S, Ganesan T, Palanisamy A NPJ Syst Biol Appl. 2024; 10(1):53.

PMID: 38760412 PMC: 11101644. DOI: 10.1038/s41540-024-00378-w.


Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.

Danielpour D Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675493 PMC: 11054419. DOI: 10.3390/ph17040533.